Biomarker Discovery & Validation
News on biomarker discovery and validation for research and diagnostic use in genetics, genomics, and molecular diagnostics.
Researchers Look to Validate Promising Immunotherapy Response Biomarker in Early-Stage Breast Cancer
Premium
MHC-II expression could be useful for guiding neoadjuvant immunotherapy in HER2-negative breast cancers, according to findings in Clinical Cancer Research.
Kiromic BioPharma Acquires InSilico Solutions
Kiromic expects the acquisition of the custom bioinformatics technology developer to facilitate new cancer immunotherapy discovery.
Lantern Pharma Reacquires Irofulven From Allarity Therapeutics; Plans Bladder, Prostate Cancer Trial
In reacquiring the rights to the agent, which it out-licensed in 2015, Lantern is also gaining rights to Allarity's DRP technology to predict patients' responses.
Johns Hopkins researchers have developed a single-cell, multispectral imaging platform called AstroPath for precise pathological analysis of cancer specimens.
Researchers Identify Pancreatic Cancer Biomarker That Could Improve Early Diagnosis
Testing for the biomarker pentraxin 3 could improve diagnosis and predict the efficacy of stroma-targeted treatments, according to a published study.